Search results
A Quick Glance At Apellis Pharmaceuticals Inc (NASDAQ: APLS) Stock: It Is up 52.22% From Its 52-Week...
Marketing Sentinel· 11 hours agoWhile earnings are projected to return 78.65% in 2024, the next five years will return 33.30% per annum. APLS Dividends Apellis Pharmaceuticals Inc is due ...
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 hours agoShares have added about 4% in that time frame, outperforming...500. Will the recent positive trend...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 6 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment By Investing.com
Investing.com· 1 day agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
GSK plc (NYSE:GSK) Stock Position Decreased by Peapack Gladstone Financial Corp
ETF DAILY NEWS· 10 hours agoThe institutional investor owned 23,173 shares of the pharmaceutical company’s stock after selling 1,441 shares during the quarter. Peapack Gladstone Financial Corp’s holdings ...
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoAnalysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating ...
Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Rosty Raykov Sells 2,431 Shares of Stock
ETF DAILY NEWS· 3 days agoFennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 2,431 shares of the company’s stock in a transaction on Monday, June 3rd. Following the completion ...
Crinetics Pharmaceuticals (NASDAQ:CRNX) Given “Buy” Rating at HC Wainwright
ETF DAILY NEWS· 2 days agoCrinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a note issued to investors on Tuesday ...
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks· 4 days agoFree Report) closed the most recent trading day at $78.99, moving +1.24% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.11%. Coming into today, shares of ...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 24 hours agoIn the pharmaceutical business, research to develop candidate drugs is never guaranteed to pay off,...